Alloy Genetic Medicines

Alloy Genetic Medicines is a specialized division of Alloy Therapeutics dedicated to the discovery and development of advanced RNA-based therapeutics. The company leverages its proprietary AntiClastic™ Cyclic RNA platform, which utilizes novel spatial conformations to significantly enhance the potency, stability, and therapeutic index of antisense oligonucleotides (ASOs), siRNAs, and sgRNAs. By providing democratized access to these foundational technologies, Alloy Genetic Medicines collaborates with global pharmaceutical and biotech partners to address previously undruggable targets in the central nervous system, liver, and muscle tissues. The division is led by a team of industry experts and aims to accelerate the transition of genetic medicines from discovery to clinical application through a partnership-driven ecosystem model.